PFIZER INC
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
PFE$29.36+0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Balance Sheets
Consolidated Balance Sheets
| As of December 31, | ||
|---|---|---|
| (MILLIONS, EXCEPT PER SHARE DATA) | 2024 | 2023 |
| Assets | ||
| Cash and cash equivalents | $1,043 | $2,853 |
| Short-term investments | 19,434 | 9,837 |
| Trade accounts receivable, net of allowance for doubtful accounts: 2024—$438; 2023—$470 | 11,463 | 11,566 |
| Inventories | 10,851 | 10,189 |
| Current tax assets | 3,314 | 3,978 |
| Other current assets | 4,253 | 4,911 |
| Total current assets | 50,358 | 43,333 |
| Equity-method investments | 217 | 11,637 |
| Long-term investments | 2,010 | 3,731 |
| Property, plant and equipment, net | 18,393 | 18,940 |
| Identifiable intangible assets, net | 55,411 | 64,900 |
| Goodwill | 68,527 | 67,783 |
| Noncurrent deferred tax assets and other noncurrent tax assets | 8,662 | 3,706 |
| Other noncurrent assets | 9,817 | 12,471 |
| Total assets | $213,396 | $226,501 |
| Liabilities and Equity | ||
| Short-term borrowings, including current portion of long-term debt: 2024—$3,747; 2023—$2,254 | $6,946 | $10,350 |
| Trade accounts payable | 5,633 | 6,710 |
| Dividends payable | 2,437 | 2,372 |
| Income taxes payable | 2,910 | 2,349 |
| Accrued compensation and related items | 3,838 | 2,776 |
| Deferred revenues | 1,511 | 2,700 |
| Other current liabilities | 19,720 | 20,537 |
| Total current liabilities | 42,995 | 47,794 |
| Long-term debt | 57,405 | 61,538 |
| Pension and postretirement benefit obligations | 2,115 | 2,167 |
| Noncurrent deferred tax liabilities | 2,122 | 640 |
| Other taxes payable | 6,112 | 8,534 |
| Other noncurrent liabilities | 14,150 | 16,539 |
| Total liabilities | 124,899 | 137,213 |
| Commitments and Contingencies | ||
| Common stock, $0.05 par value; 12,000 shares authorized; issued: 2024—9,593; 2023—9,562 | 480 | 478 |
| Additional paid-in capital | 93,603 | 92,631 |
| Treasury stock, shares at cost: 2024—3,926; 2023—3,916 | (114,763) | (114,487) |
| Retained earnings | 116,725 | 118,353 |
| Accumulated other comprehensive loss | (7,842) | (7,961) |
| Total Pfizer Inc. shareholders’ equity | 88,203 | 89,014 |
| Equity attributable to noncontrolling interests | 294 | 274 |
| Total equity | 88,497 | 89,288 |
| Total liabilities and equity | $213,396 | $226,501 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.